In Brief This Week: Fluidigm, Life Tech; Bio-Rad; Viracor-IBT Laboratories; PositiveID; ArrayIt; Peaccel, Polyclone; Cofactor Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm said in its Form 10-Q last week that it will pay Life Technologies $1.0 million as part of a cross-license agreement reached between Fluidigm and Life Tech's Applied Biosystems business. Life Tech notified Fluidigm in mid-October that the payment is due and payable under the license agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.